Natrol
This article was originally published in The Tan Sheet
Executive Summary
Fourth quarter sales expected to fall roughly 13.3% to $15.6 mil. from $18 mil. in year-ago period, according to preliminary results released Feb. 8. Net sales for 2001 should reach about $76.2 mil., down 12.5%, firm reports. Natrol attributes decline to weakening drug channel, higher returns. Chatsworth, Calif.-based firm notes it will take a $20 mil. impairment charge for 2001, writing down the value of goodwill associated with its 1999 acquisition of Prolab Nutrition, which has posted disappointing financials...